The DOI matches its Crossref record.
Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
Abstract
Fasting and postprandial plasma glucose, free fatty acid (FFA), lactate, and insulin concentrations were measured at hourly intervals for 24 h in 27 nonobese individuals—9 with normal glucose tolerance, 9 with mild non-insulin-dependent diabetes mellitus (NIDDM, fasting plasma glucose < 175 mg/dl), and 9 with severe NIDDM (fasting plasma glucose > 250 mg/dl). In addition, hepatic glucose production (HGP) was measured from midnight to 0800 in normal individuals and patients with severe NIDDM. Plasma glucose concentration was highest in patients with severe NIDDM, lowest in those with normal glucose tolerance, and intermediate in those with mild NIDDM (two-way ANOVA, P < .001). Variations in plasma FFA and lactate levels of the three groups were qualitatively similar, with lowest concentrations seen in normal individuals, intermediate levels in the group with mild NIDDM, and the highest concentration in those with severe NIDDM (two-way ANOVA, P < .001). Of particular interest was the observation that plasma FFA concentrations were dramatically elevated from midnight to 0800 in patients with severe NIDDM. The 24-h insulin response was significantly increased in patients with mild NIDDM, with comparable values seen in the other two groups. Values for HGP fell progressively throughout the night in normal individuals and patients with severe NIDDM, despite a concomitant decline in plasma glucose and insulin levels. Although the magnitude of the fall in HGP was greater in NIDDM, the absolute value was significantly (P < .001) greater than normal throughout the period of observation. These results demonstrate that there are differences in substrate level between individuals with normal glucose tolerance and patients with NIDDM and differing degrees of glucose intolerance, unrelated to ambient insulin level, and these changes persist over 24 h.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metabolic derangements of Type 2 diabetes include an increase in plasma NEFA concentrations [145], which has been shown to produce deleterious effects on the insulin-sensitive tissues and the beta cell.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [145]
In the citing paper
“Nondiabetic obese and type 2 diabetic individuals are characterized by day-long elevation in the plasma FFA concentration, which fails to suppress normally after ingestion of a mixed meal or an oral glucose load [60].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [60]
In the citing paper
“these results suggest that increased hepatic de novo lipogenesis precede the development of adipose tissue insulin resistance, which subsequently leads to increased flux of fatty acids to the liver (16, 17).”
From The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome (2007) · cites this paper as [17]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 401–500 of 749
Ku, C. S., Park, Y., Coleman, S. L., & Lee, J. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.07.007 · Cited by 31
Christensen, N. L., Jakobsen, S., Schacht, A. C., Munk, O. L., Alstrup, A. K. O., Tolbod, L. P., Harms, H. J., Nielsen, S., & Gormsen, L. C. (2017) · Molecular Imaging · doi:10.1177/1536012117734485 · Cited by 30
Patel, R., Palit, S. P., RATHWA, N. N., Ramachandran, A. V., & Begum, R. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.06.962 · Cited by 30
Alterations of Glucose Metabolism in Type 2 Diabetes Mellitus. An Overview
Bonadonna, R. C. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000021429.89218.c6 · Cited by 29
Wang, M., & Fotsch, C. H. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.010 · Cited by 30
Li, Y., Lu, C., Wang, Y., Li, Y., & Li, X. (2014) · Journal of Diabetes Research · doi:10.1155/2014/391476 · Cited by 29
Kim, S. K., Oh, E., Yun, M., Lee, S., & Chae, G. T. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0077-3 · Cited by 29
Song, Y., Zhang, L., Li, H., Gu, Y., Li, F., Jiang, L., Liu, F., Ye, J., & Li, Q. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-111 · Cited by 29
Characteristics of the Insulin Resistance Syndrome in a Japanese Population
Kario, K., Nago, N., Kayaba, K., Saegusa, T., Matsuo, H., Goto, T., Tsutsumi, A., Ishikawa, S., Kuroda, T., Miyamoto, T., et al. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.2.269 · Cited by 29
Le, Y., Wei, R., Yang, K., Lang, S., Gu, L., Liu, J., Hong, T., & Yang, J. (2019) · Peptides · doi:10.1016/j.peptides.2019.170212 · Cited by 28
Virtual metabolic human dynamic model for pathological analysis and therapy design for diabetes
Kurata, H. (2021) · iScience · doi:10.1016/j.isci.2021.102101 · Cited by 26
Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes
Phillips, C. M., Owens, D., Collins, P. B., & TOMKIN, G. H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.033 · Cited by 28
Rui, Y., Tong, L., Cheng, J., Wang, G., Qin, L., & Wan, Z. (2017) · Food & Nutrition Research · doi:10.1080/16546628.2017.1330096 · Cited by 28
Lipid Oxidation Assessed by Indirect Calorimetry Predicts Metabolic Syndrome and Type 2 Diabetes
Pujia, A., Mazza, E., Ferro, Y., Gazzaruso, C., Coppola, A., Doldo, P., Grembiale, R. D., Pujia, R., Romeo, S., & Montalcini, T. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00806 · Cited by 28
Fatty acid-induced atherogenic changes in extracellular matrix proteoglycans
Rodrı́guez-Lee, M., Bondjers, G., & Camejo, G. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ef534f · Cited by 27
Binding of [3H]palmitate to BSA
Elmadhoun, B., Wang, G. Q., Templeton, J. F., & Burczynski, F. J. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.4.g638 · Cited by 28
Sparks, L. M., Bosma, M., Brouwers, B., van de Weijer, T., Bilet, L., Schaart, G., Moonen‐Kornips, E., Eichmann, T. O., Lass, A., Hesselink, M. K. C., et al. (2014) · Diabetes · doi:10.2337/db13-1123 · Cited by 28
Blindauer, C. A., Khazaipoul, S., Yu, R., & Stewart, A. J. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160216155927 · Cited by 27
Samsonov, M. V., Podkuychenko, N. V., Khapchaev, A. Y., Efremov, E. E., Yanushevskaya, E. V., Vlasik, T. N., Lankin, V. Z., Stafeev, I., Skulachev, M. V., Шестакова, М. В., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010211 · Cited by 29
Palmitate-induced skeletal muscle insulin resistance does not require NF-κB activation
Hommelberg, P. P. H., Plat, J., Sparks, L. M., Schols, A. M. W. J., van Essen, A. L. M., KELDERS, M. C. J. M., van Beurden, D., Mensink, R. P., & LANGEN, R. C. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0515-3 · Cited by 27
Gao, Z., Zhang, C., Yu, S., Yang, X., & Wang, K. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0780-0 · Cited by 27
Insulin Increases Ceramide Synthesis in Skeletal Muscle
Hansen, M. E., Tippetts, T. S., Anderson, M. C., Holub, Z. E., Moulton, E. R., Swensen, A., Prince, J. T., & Bikman, B. T. (2014) · Journal of Diabetes Research · doi:10.1155/2014/765784 · Cited by 28
Shi, Y., Zhang, Y., Tian, H., Wang, Y., Shen, Y., Zhu, Q., & Ding, F. H. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz079 · Cited by 27
Girard, J. R. (2003) · médecine/sciences · doi:10.1051/medsci/20031989827 · Cited by 35
Insulin secretory function in Type 2 diabetes: Does it matter how you measure it?
Reaven, G. M. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00016.x · Cited by 26
Self-citationTraining status diverges muscle diacylglycerol accumulation during free fatty acid elevation
Chow, L. S., Mashek, D. G., Austin, E. E., Eberly, L. E., Persson, X.-M. T., Mashek, M. T., Seaquist, E. R., & Jensen, M. D. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00166.2014 · Cited by 27
Ghimire, B. K., Yu, C. Y., & Chung, I. (2017) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2017.06.006 · Cited by 26
Domínguez‐Riscart, J., Buero-Fernandez, N., García-Zarzuela, A., Morales-Perez, C., García-Ojanguren, A., & Lechuga-Sancho, A. M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.813989 · Cited by 29
Mahmmoud, Y. A., & Christensen, S. B. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.06.025 · Cited by 26
Du, X., JIANG, Y., Weijun, Q. I. A. N., Lu, X., & WALSH, J. P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570275 · Cited by 26
Kim, D. M., Lee, J. H., Pan, Q., Han, H. W., Shen, Z., Eshghjoo, S., Wu, C., Yang, W., Noh, J. Y., Threadgill, D. W., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101852 · Cited by 28
Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitus
Triplitt, C. L., & DeFronzo, R. A. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.3.329 · Cited by 25
Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis
Kehlenbrink, S., Koppaka, S., Martin, M., Relwani, R., Cui, M., Hwang, J.-H., Li, Y., Basu, R., Hawkins, M. A., & Kishore, P. (2012) · Diabetologia · doi:10.1007/s00125-012-2662-6 · Cited by 24
Axelsen, M., Lönnroth, P., Lenner, R. A., Taskinen, M., & Smith, U. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1108 · Cited by 24
Hepatic glucose production: therapeutic target in type 2 diabetes?
Stæhr, P., Nielsen, O. H., & Beck‐Nielsen, H. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00177.x · Cited by 25
Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?
Huang, W., Castelino, R. L., & Peterson, G. M. (2014) · Internal Medicine Journal · doi:10.1111/imj.12369 · Cited by 24
Oleic Acid Induces MiR-7 Processing through Remodeling of Pri-MiR-7/Protein Complex
Kumar, S., Velasco, A. D. R., & Michlewski, G. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.05.001 · Cited by 24
Regulation of hepatic metabolism by enteral delivery of nutrients
Dardevet, D. P., Moore, M. C., Rémond, D., Grueter, C. A., & Cherrington, A. D. (2006) · Nutrition Research Reviews · doi:10.1017/s0954422407315175 · Cited by 26
Determination of Free Fatty Acids in Human Serum by HPLC with Fluorescence Detection
Nishikiori, M., Iizuka, H., Ichiba, H., Sadamoto, K., & Fukushima, T. (2014) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmu081 · Cited by 24
Free fatty acids as target for therapy
Boden, G. H. (2004) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000141928.95173.63 · Cited by 24
Neurobiological characteristics underlying metabolic differences between males and females
Chowen, J. A., Freire‐Regatillo, A., & Argente, J. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.09.001 · Cited by 24
de Almeida, M. E., Ørtenblad, N., Petersen, M. H., Schjerning, A., Wentorf, E. K., Jensen, K., Højlund, K., & Nielsen, J. (2023) · The Journal of Physiology · doi:10.1113/jp284386 · Cited by 24
Levels of inflammatory markers and their correlation with dyslipidemia in diabetics.
Waheed, P., Naveed, A. K., & Farooq, F. (2009) · PubMed · Cited by 22
Plasma lipidomic signatures of spontaneous obese rhesus monkeys
Wang, J., Zhang, L., Xiao, R., Li, Y., Liao, S., Zhang, Z., Yang, W., & Liang, B. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-018-0952-9 · Cited by 23
Fat-induced liver insulin resistance
Shah, P., Basu, A., & Rizza, R. A. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0066-1 · Cited by 23
Ginseng Extract Inhibits Lipolysis in Rat Adipocytes In Vitro by Activating Phosphodiesterase 4
Wang, H., Reaves, L. A., & Edens, N. K. (2006) · Journal of Nutrition · doi:10.1093/jn/136.2.337 · Cited by 23
Heterogeneity in limb fatty acid kinetics in type 2 diabetes
Sacchetti, M., Olsen, D. B., Saltin, B., & van Hall, G. (2005) · Diabetologia · doi:10.1007/s00125-005-1727-1 · Cited by 23
McCarty, M. F. (2002) · Medical Hypotheses · doi:10.1054/mehy.2001.1456 · Cited by 24
Ge, G., Ai, C., Hu, W., Hou, J., Zhu, L., He, G.-Y., Fang, Z., Liang, S., Wang, F., & Yang, L. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.11.011 · Cited by 22
Paik, J., Cho, W., Oh, E., Lee, S., & Yang, S.-W. (2012) · Europe PMC (PubMed Central) · Cited by 22
Singh, B. M., Krentz, A., & Nattrass, M. (1993) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(93)90023-x · Cited by 21
Adipose tissue insulin resistance in adolescents with and without type 2 diabetes
Kelsey, M. M., Forster, J. E., Pelt, R. E. V., Reusch, J. E. B., & Nadeau, K. J. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00189.x · Cited by 22
Yin, W., Liao, D., Wang, Z., Xi, S., Tsutsumi, K., Koike, T., Fan, J., Yi, G., Zhang, Q., Yuan, Z., et al. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.008 · Cited by 22
Iannello, S., Campione, R., & Belfiore, F. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1997.2670 · Cited by 22
Dobbins, R. L., Byerly, R., Gaddy, R., Gao, F., Mahar, K. M., Napolitano, A., Ambery, P., & de Gouville, A. L. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.005 · Cited by 21
DeFronzo, R. A., Triplitt, & Cersosimo (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4852 · Cited by 23
Lee, S., Boesch, C., Kuk, J. L., & Arslanian, S. A. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.007 · Cited by 21
Rostamirad, A., Ebrahimi, S. S. S., Sadeghi, A., Taghikhani, M., & Meshkani, R. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.041 · Cited by 21
Exercise—A Panacea of Metabolic Dysregulation in Cancer: Physiological and Molecular Insights
Raun, S. H., Buch‐Larsen, K., Schwarz, P., & Sylow, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073469 · Cited by 20
Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism
Li, X., Cai, P., Tang, X., Wu, Y., Zhang, Y., & Rong, X. (2024) · Metabolites · doi:10.3390/metabo14040217 · Cited by 23
Intracellular lipid accumulation and shift during diabetes progression
Wolf, P. S., Winhofer, Y., Anderwald, C. H., Krššák, M., & Krebs, M. (2014) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-014-0292-y · Cited by 20
Effect of exercise on lipolysis in adipose tissue
Polak, J., Bajzová, M., & Štich, V. (2008) · Future Lipidology · doi:10.2217/17460875.3.5.557 · Cited by 22
Grizzanti, J., Lee, H., Camins, A., Pallàs, M., & Casadesús, G. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.11.002 · Cited by 21
Time-Dependent Effects of Free Fatty Acids on Glucose Effectiveness in Type 2 Diabetes
Kishore, P., Tonelli, J., Koppaka, S., Fratila, C., Bose, A., Lee, D.-E., Reddy, K., & Hawkins, M. A. (2006) · Diabetes · doi:10.2337/db05-0988 · Cited by 21
Lu, X., Yang, X.-Y., Howard, R. L., & Walsh, J. P. (2000) · Diabetologia · doi:10.1007/s001250051504 · Cited by 20
Intracellular Long-Chain Acyl CoAs Activate TRPV1 Channels
Yu, Y., Carter, C. R. J., Youssef, N., Dyck, J. R. B., & Light, P. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096597 · Cited by 20
Palomo, I. F. (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000125 · Cited by 19
Kannan, S., Srinivasan, D., Raghupathy, P. B., & Bhaskaran, R. S. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.05.012 · Cited by 19
Toward a wholly nutritional therapy for type 2 diabetes
McCarty, M. F. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0881 · Cited by 19
Emilsson, V., O’Dowd, J. F., Nolan, A. L., & Cawthorne, M. A. (2001) · Endocrinology · doi:10.1210/endo.142.10.8414 · Cited by 19
Higashiura, Y., Tanaka, M., Furuhashi, M., Koyama, M., Ohnishi, H., Numata, K., Hisasue, T., Hanawa, N., Moniwa, N., & Miura, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13284 · Cited by 18
Obesity, Anion Accumulation, and Anion Gap Metabolic Acidosis: A Cohort Study
Lambert, D. C., & Abramowitz, M. K. (2021) · Kidney360 · doi:10.34067/kid.0003562021 · Cited by 18
Mubtasim, N., & Gollahon, L. (2023) · Life · doi:10.3390/life13081712 · Cited by 20
Choi, S., KANG, Y. Y., Jang, H.-J., Shin, H.-C., Kim, H.-E., Kim, H.-S., Kim, H. J., Kim, D. J., & Lee, K. W. (2007) · Journal of Vascular Research · doi:10.1159/000102321 · Cited by 18
Milardi, D., Sciacca, M. F. M., Randazzo, L., Raudino, A., & Rosa, C. L. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00216 · Cited by 19
Intracellular pH Regulation of Skeletal Muscle in the Milieu of Insulin Signaling
Posa, D. K., & Baba, S. P. (2020) · Nutrients · doi:10.3390/nu12102910 · Cited by 19
Prokineticin receptor 1 ameliorates insulin resistance in skeletal muscle
Mok, J., Park, T. S., Kim, S., Kim, D., Choi, C. S., & Park, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001641r · Cited by 18
Colette, C., Ginet, C., Boegner, C., Bénichou, M., Pham, T. C., Cristol, J., & Monnier, L. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01482.x · Cited by 18
Complementary measures for promoting insulin sensitivity in skeletal muscle
McCarty, M. F. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90065-2 · Cited by 19
Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism
Chambrier, C., Picard, S., Vidal, H., Cohen, R., Riou, J. P., & Beylot, M. (1990) · Metabolism · doi:10.1016/0026-0495(90)90311-y · Cited by 18
Partners in diabetes epidemic: A global perspective
Wang, H., Akbari‐Alavijeh, S., Parhar, R. S., Gaugler, R. R., & Hashmi, S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i10.1463 · Cited by 17
Alteration of hypothalamic glucose and lactate sensing in 48 h hyperglycemic rats
Allard, C., Carneiro, L., Collins, S. C., Chrétien, C., Grall, S., Pénicaud, L., & Leloup, C. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.11.033 · Cited by 17
Cyclosporine A and palmitic acid treatment synergistically induce cytotoxicity in HepG2 cells
Luo, Y., Rana, P., & Will, Y. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.03.022 · Cited by 17
Thomas, F., Smith, G. C., Lu, J., Babor, R., Booth, M., Beban, G. R., Chase, J. G., & Murphy, R. (2016) · Obesity Surgery · doi:10.1007/s11695-015-2038-3 · Cited by 17
Higuchi, I., Kimura, Y., Kobayashi, M., Narumi, K., Furugen, A., Miyoshi, H., Nakamura, A., Yamada, T., Atsumi, T., & Iseki, K. (2019) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2019.10.001 · Cited by 17
A Rat Model of Human Lipid Emulsion Digestion
Steingoetter, A., Arnold, M., Scheuble, N., Fedele, S., Bertsch, P., Liu, D., Parker, H. L., Langhans, W., & Fischer, P. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00170 · Cited by 18
Iannello, S., Camuto, M., Cavaleri, A., Milazzo, P., Pisano, M. G., Bellomia, D., & Belfiore, F. (2003) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00306.x · Cited by 17
Fatty acids and insulin secretion
Amery, C. M., & Nattrass, M. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00059.x · Cited by 18
Serum fatty acids in postinfarction middle‐aged men
Leskinen, M. H., Solakivi, T., Kunnas, T. A., Alho, H., & Nikkari, S. T. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510025836 · Cited by 17
Oyabambi, A. O., Olaniyi, K. S., Soladoye, A. O., & Olatunji, L. A. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103452 · Cited by 16
A Lupinoside prevented fatty acid induced inhibition of insulin sensitivity in 3T3 L1 adipocytes
Dey, D., Pal, B. C., Biswas, T., Roy, S. S., Bandyopadhyay, A., Mandal, S. K., Giri, B. B., & Bhattacharya, S. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9378-1 · Cited by 17
Murine intramyocellular lipids quantified by NMR act as metabolic biomarkers in burn trauma
Tzika, A. A., Astrakas, L. G., Cao, H., Mintzopoulos, D., Zhang, Q., Padfield, K. E., Yu, H., Mindrinos, M. N., Rahme, L. G., & Tompkins, R. G. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.6.825 · Cited by 15
Nagaraju, R., & Rajini, P. S. (2016) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2016.04.009 · Cited by 17
Scanlon, G., Loughman, J., Farrell, D., & McCartney, D. M. A. (2019) · Nutrition Research Reviews · doi:10.1017/s095442241900012x · Cited by 17
Role of the kidney in hyperglycemia in type 2 diabetes
Meyer, C., & Gerich, J. E. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0089-z · Cited by 16
Obesity, insulin resistance, Type 2 diabetes and free fatty acids
Boden, G. H. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.4.499 · Cited by 16
Fatty acids modulate the effect of darglitazone on macrophage CD36 expression
Svensson, L., Camejo, G., Cabré, A., Vallvé, J.-C., Pedreño, J., Norén, K., Wiklund, O., & Hultén, L. M. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01181.x · Cited by 16
Obesity and Depression: Common Link and Possible Targets
Jitte, S., Keluth, S., Bisht, P., Wal, P., Singh, S., Murti, K., & Kumar, N. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273291985240430074053 · Cited by 15
García‐Layana, A., Figueroa, M. S., Arias, L., Adán, A., López, F. A. C., Abraldes, M. J., Fernández‐Vega, Á., Navarro, R., Cervera, E., da Silva, R. M., et al. (2018) · Ophthalmologica · doi:10.1159/000486800 · Cited by 15
The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 15
Metadata
- Authors
- Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I.
- Affiliations
- VA Palo Alto Health Care System (US)
- ORCID
- Chen, Yii-Der Ida
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1988-08-01
- Volume
- 37
- Issue
- 8
- Pages
- 1020-1024
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2109820048
- Cited by
- 753
- References
- 0
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 13 · 2023: 13 · 2022: 6 · 2021: 21 · 2020: 27 · 2019: 22 · 2018: 25 · 2017: 32 · 2016: 27 · 2015: 28 · 2014: 37 · 2013: 34 · 2012: 27
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK30732)
- National Center for Research Resources (RR-00070-26)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, plasma glucose, free fatty acids, lactate, insulin response, hepatic glucose production, circadian variation, fasting blood glucose, postprandial blood glucose, glucose tolerance
- MeSH terms
- Blood Glucose, Circadian Rhythm, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Humans, Insulin, Lactates, Monitoring, Physiologic, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review